|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0013227,
umls-concept:C0019163,
umls-concept:C0023290,
umls-concept:C0030705,
umls-concept:C0042769,
umls-concept:C0086466,
umls-concept:C0422792,
umls-concept:C1272883,
umls-concept:C1272936,
umls-concept:C1533685,
umls-concept:C2603343
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2001-3-14
|
|
pubmed:abstractText |
Human immunodeficiency virus (HIV) and hepatitis B and hepatitis C viruses have emerged as major blood-borne infections. Several cases of infections through the use of unsterile injection needles also are on record. Kala-azar, or visceral leishmaniasis, is a hemoparasitic disease caused by Leishmania donovani. All the anti-kala-azar medications require multiple intramuscular injections of the anti-leishmanial drugs. To find whether these patients were at higher risk of contracting blood-borne infection, than those who were not on medication, a community-based study was conducted in the kala-azar-endemic state of Bihar, India.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1201-9712
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
203-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11231183-Adolescent,
pubmed-meshheading:11231183-Adult,
pubmed-meshheading:11231183-Amphotericin B,
pubmed-meshheading:11231183-Antimony Sodium Gluconate,
pubmed-meshheading:11231183-Antiprotozoal Agents,
pubmed-meshheading:11231183-Child,
pubmed-meshheading:11231183-Equipment Contamination,
pubmed-meshheading:11231183-Female,
pubmed-meshheading:11231183-HIV Antibodies,
pubmed-meshheading:11231183-HIV Infections,
pubmed-meshheading:11231183-Hepatitis B,
pubmed-meshheading:11231183-Hepatitis B Surface Antigens,
pubmed-meshheading:11231183-Hepatitis C,
pubmed-meshheading:11231183-Hepatitis C Antibodies,
pubmed-meshheading:11231183-Humans,
pubmed-meshheading:11231183-India,
pubmed-meshheading:11231183-Injections, Intramuscular,
pubmed-meshheading:11231183-Leishmaniasis, Visceral,
pubmed-meshheading:11231183-Male,
pubmed-meshheading:11231183-Needles,
pubmed-meshheading:11231183-Pentamidine,
pubmed-meshheading:11231183-Prevalence,
pubmed-meshheading:11231183-Social Class
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study.
|
|
pubmed:affiliation |
Department of Laboratory Medicine, All India Institute of Medical Sciences, New Delhi-110029, India. ssingh@medinst.ernet.in (and/or) ssingh56@hotmail.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
